Last updated on August 2019

A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis


Brief description of study

The purpose of this study is to evaluate the efficacy and safety of mirikizumab as maintenance therapy in participants who completed prior 12-week induction study AMAN (NCT03518086).

Clinical Study Identifier: NCT03524092

Find a site near you

Start Over

The Northern Hospital

Epping, Australia
0.43miles
  Connect »